RxDoctor Payments Data

Peter Gates, MD

Family Medicine · New London, CTNPI 1154416782

Payments from drug & device makers

$619in general payments, 2019–2025

Across 26 payments — averaging $23.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$112
  • Boehringer Ingelheim$78
  • AbbVie$70
  • Lilly USA, LLC$66
  • Novo Nordisk$64
  • Baxter Healthcare$33
  • plus $196 from 9 others

What the payments were for

  • Food & beverage$619100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$619 in reported general payments places this provider in the 65th percentile of 588 family medicine providers in Connecticut.

See all family medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$78,871
Medicare patients
189
Services billed
746

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban77$74,001
JardianceEmpagliflozin36$55,702
OzempicSemaglutide41$39,896
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$27,651
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog26$21,986
MounjaroTirzepatide18$18,796
XareltoRivaroxaban17$13,619
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$5,226
Atorvastatin Calcium342$3,815
Tolterodine Tartrate ErTolterodine Tartrate26$2,559
Albuterol Sulfate HfaAlbuterol Sulfate72$2,395
Omeprazole126$1,928
Fesoterodine Fumarate ErFesoterodine Fumarate17$1,747
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$1,647
Amlodipine Besylate230$1,616

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$18$74,00177 claims
Boehringer IngelheimJardiance$78$55,70236 claims
Novo NordiskOzempic$64$39,89641 claims
GSKTrelegy Ellipta$25$27,65117 claims
Lilly USA, LLCMounjaro$66$18,79618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 588 family medicine providers in Connecticut.

Other family medicine in New London

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →